Gravar-mail: ATCT-07 PHASE 2 STUDY OF MEDI-575, AN ANTI-PLATELET-DERIVED GROWTH FACTOR-α ANTIBODY, IN PATIENTS WITH RECURRENT GLIOBLASTOMA